What’s New!
When Large-Language-Models Make Sense: A Game Changer for Enterprises
At EDBI’s inaugural masterclass in collaboration with NVIDIA, we delved into the world of Large Language Models (LLM) and glimpsed into the opportunities and challenges in its landscape led by Dr. Ettikan K Karuppiah, director and technologist and Dr. Deb Goswani, head of developer programs - big data and analytics at NVIDIA.
A recipe for success: How to thrive in Southeast Asia alternative protein market
Singapore has taken bold steps in accelerating innovation in the agrifood landscape in the recent years. For instance, while global regulators grappled with how to regulate cell-based foods, Singapore Food Agency (SFA) broke the impasse by becoming the first to grant regulatory approval for cell-based meat in 2021.
Ambiq Achieves Milestone of Powering Over 200 Million IoT Devices
Austin, TX and Singapore, 13 June 2023 – Ambiq®, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, achieved a key milestone of powering over 200 million IOT devices earlier this year.
AR startup Magic Leap raises USD461 million from Saudi Arabia fund
(Reuters) – Magic Leap, a secretive startup working in the augmented reality space, said on Wednesday it raised $461 million in its latest funding round, led by the Kingdom of Saudi Arabia’s sovereign investment arm.
- 8 Mar 2018
Tessa Therapeutics – Bright sparks in the biomedical sector
Singapore-based biotechnology firm Tessa Therapeutics (Tessa) has come a long way from the Singapore cafe where the idea of its inception was hatched.
- 4 Mar 2018
PEAR Therapeutics to Collaborate with Novartis to Develop Prescription Digital Therapeutics
BOSTON, and SAN FRANCISCO, March 1, 2018—PEAR Therapeutics announced today that it has entered into a collaboration with Novartis to develop novel prescription digital therapeutics for schizophrenia and multiple sclerosis (MS).
- 1 Mar 2018
Moderna Closes USD500 Million Equity Financing
CAMBRIDGE, Mass., February 1, 2018 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for high unmet medical needs in patients, today announced that it has raised $500 million in a new funding round.
- 1 Feb 2018
Joby Aviation Secures USD100M in Series B Funding to Make Electric Vertical Take-off and Landing Transportation a Reality
SANTA CRUZ, Calif. – February 1, 2018 – Joby Aviation announced it has secured $100M in Series B financing to take its all-electric vertical take-off and landing (eVTOL) passenger aircraft into pre-production and certification.
- 1 Feb 2018
Engine Biosciences Raises USD10 Million in Largest Institutional Seed Financing Seen in South East Asia
Singapore and San Francisco-based biotech company raises US$10 million in seed round from leading American and Asian investors; round was co-led by DHVC (Danhua Capital) and 6 Dimensions Capital, with participation from WuXi Apptec, EDBI, Pavilion Capital, Baidu Ventures, WI Harper, and Nest.Bio Ventures.
- 31 Jan 2018
Yang Kee Logistics completes SGD52.1m acquisition of New Zealand peer Fliway
YANG Kee Logistics on Thursday said it has completed the acquisition of New Zealand listed company, Fliway Group, for S$52.1 million – making it the first and largest Singaporean third-party logistics player to operate in New Zealand and the Oceania region.
- 4 Jan 2018
EDBI Participates in PEAR Therapeutics’ USD50 Million Series B Financing Round
BOSTON, and SAN FRANCISCO, January 2, 2018– PEAR Therapeutics, the leader in prescription digital therapeutics, today announced that it has successfully closed a $50 million Series B financing led by Temasek. With this financing, Temasek joins new and existing investors including 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, Singapore-based EDBI, and the Bridge Builder’s Collaborative.
- 2 Jan 2018
Magic Leap CEO interview: Indoor augmented reality is the first step
Rony Abovitz has been dreaming about a new way of seeing the world since he started Magic Leap in 2011. He raised $1.9 billion in funding, but he stayed quiet about what the company was going to do. Today, he unveiled the Magic Leap One AR goggles for the first time. AR is expected to be a multibillion market, with support from Google and Apple, but Magic Leap is the company that is throwing the most money and people at the challenge today.
- 20 Dec 2017
EDBI participates in Tessa Therapeutics’ USD 80 Million Financing Round
SINGAPORE – 20 December 2017 – Tessa Therapeutics, an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors, today announced the completion of a USD 80 million financing round led by Temasek, an investment company headquartered in Singapore, and joined by EDBI, Karst Peak Capital, Heliconia, Heritas and other investors.
- 20 Dec 2017
